ZFP36L2 as a Prognostic Marker in Osteosarcoma
Author Information
Author(s): Hao Peiyao, Luo Piaopiao, Xu Shenglin, Ren Zhenhua, Zhao Hong
Primary Institution: Anhui Medical University
Hypothesis
ZFP36L2 plays an important role in tumor progression and is a potential biomarker for IL1β-high osteosarcoma.
Conclusion
ZFP36L2 has potential as a prognostic marker in IL1β+ osteosarcoma patients.
Supporting Evidence
- ZFP36L2 is associated with metastasis in sarcoma.
- ZFP36L2 has been shown to be associated with T cells and macrophages in the tumor microenvironment.
- High ZFP36L2 expression correlates with better prognosis in IL1β-high osteosarcoma.
Takeaway
ZFP36L2 is a protein that might help doctors understand how serious osteosarcoma is in patients with high levels of IL1β, which is a marker of inflammation.
Methodology
RNA-seq data from TCGA and GTEx cohorts were analyzed, along with immune infiltration and survival analysis using Kaplan–Meier curves.
Limitations
The study lacks in vitro experiments for validation and requires a larger cohort for more comprehensive patient information.
Participant Demographics
Patients with osteosarcoma, primarily children and young adults.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website